Literature DB >> 9854979

Systematic review of antifibrinolytic treatment in aneurysmal subarachnoid haemorrhage.

Y B Roos1, M Vermeulen, G J Rinkel, A Algra, J Van Gijn, A Algra.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9854979      PMCID： PMC2170374          DOI： 10.1136/jnnp.65.6.942

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  8 in total

1.  Effect of tranexamic acid on rebleeding after subarachnoid hemorrhage: a double-blind controlled clinical trial.

Authors:  J van Rossum; A R Wintzen; L J Endtz; J H Schoen; H de Jonge
Journal:  Ann Neurol       Date:  1977-09       Impact factor: 10.422

2.  Prolonged antifibrinolysis: an effective non-surgical treatment for ruptured intracranial aneurysms?

Authors:  R S Maurice-Williams
Journal:  Br Med J       Date:  1978-04-15

3.  The use of antifibrinolytic agents in the preoperative treatment of ruptured intracranial aneurysms.

Authors:  J P Girvin
Journal:  Trans Am Neurol Assoc       Date:  1973

4.  Benefits and risks of antifibrinolytic therapy in the management of ruptured intracranial aneurysms. A double-blind placebo-controlled study.

Authors:  S A Tsementzis; E R Hitchcock; C H Meyer
Journal:  Acta Neurochir (Wien)       Date:  1990       Impact factor: 2.216

5.  Antifibrinolytic treatment in subarachnoid hemorrhage.

Authors:  M Vermeulen; K W Lindsay; G D Murray; F Cheah; A Hijdra; J P Muizelaar; M Schannong; G M Teasdale; H van Crevel; J van Gijn
Journal:  N Engl J Med       Date:  1984-08-16       Impact factor: 91.245

6.  Treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm with tranexamic acid: a double-blind clinical trial.

Authors:  B Chandra
Journal:  Ann Neurol       Date:  1978-06       Impact factor: 10.422

7.  Antifibrinolysis with tranexamic acid in aneurysmal subarachnoid hemorrhage: a consecutive controlled clinical trial.

Authors:  H Fodstad; A Forssell; B Liliequist; M Schannong
Journal:  Neurosurgery       Date:  1981-02       Impact factor: 4.654

8.  Tranexamic acid in subarachnoid hemorrhage. A double-blind study.

Authors:  M Kaste; M Ramsay
Journal:  Stroke       Date:  1979 Sep-Oct       Impact factor: 7.914
  8 in total
  3 in total

Review 1.  Coagulopathy in traumatic brain injury.

Authors:  Sherman C Stein; Douglas H Smith
Journal:  Neurocrit Care       Date:  2004       Impact factor: 3.210

Review 2.  Subarachnoid haemorrhage: epidemiology, risk factors, and treatment options.

Authors:  G J Kaptain; G Lanzino; N F Kassell
Journal:  Drugs Aging       Date:  2000-09       Impact factor: 3.923

Review 3.  Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage.

Authors:  Merih I Baharoglu; Menno R Germans; Gabriel J E Rinkel; Ale Algra; Marinus Vermeulen; Jan van Gijn; Yvo B W E M Roos
Journal:  Cochrane Database Syst Rev       Date:  2013-08-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.